
Active monitoring:
MGUS and many cases of smouldering multiple myeloma are monitored rather than treated immediately when there are no myeloma-defining complications.

From diagnosis and treatment planning to remission, maintenance and follow-up, experience care that considers your strength, bone health, nutrition, comfort and overall wellbeing.

A diagnosis can bring many questions at once. Let us begin with the basics.
Multiple myeloma is a blood cancer that begins in plasma cells in the bone marrow. Healthy plasma cells produce antibodies that help fight infections. In multiple myeloma, abnormal plasma cells build up and may produce an abnormal monoclonal protein, also called M protein or paraprotein. The disease can cause anaemia, fatigue, frequent infections, bone pain or fractures, high calcium levels and kidney damage. It is not a primary bone cancer, although it commonly affects bones and can cause areas of bone loss called lytic lesions. Diagnosis may involve blood and urine tests, bone marrow biopsy, FISH testing and imaging such as CT, PET-CT or MRI.
Your haematologist may have discussed combination medicines, stem cell transplantation, maintenance therapy or newer immune-based treatments. Treatment depends on whether the disease is active, chromosome findings, kidney function, overall fitness, previous treatment and whether transplantation is suitable.

Cancer Healer Therapy (CAM) is supportive integrative care used alongside treatment prescribed by your haematologist or oncologist, not instead of it.
The supportive plan may consider appetite, fatigue, sleep, mobility, emotional wellbeing and the practical demands of prolonged treatment.
Multiple myeloma can affect the kidneys, bones, calcium levels and immune system. Herbal medicines and supplements may interact with cancer treatments or worsen kidney, liver, bleeding or infection-related problems.
Support may begin before systemic treatment or transplantation, with attention to blood counts, kidney function, calcium, bone pain, nutrition, mobility and current medicines.


Here’s exactly what happens from your first conversation with us to ongoing support during treatment.
We discuss your diagnosis, bone marrow report, blood and urine results, imaging, symptoms and current treatment.
The team reviews whether the condition is MGUS, smouldering or active myeloma, chromosome findings, kidney function, calcium levels, blood counts, bone symptoms and treatment plan.
Supportive care is developed around the treatment or monitoring plan recommended by your haematology team.
Herbal medicines, supplements and special diets should be disclosed to your treating haematologist.
The plan may be reviewed as symptoms, blood tests, imaging and treatment needs change.
One point of contact supports appointments and follow-up communication.

Meet Dr. Tarang Krishna, MD - Cancer Healer Center
Dr. Tarang Krishna has spent over two decades developing and refining Cancer Healer Therapy, working with a multidisciplinary team across 30+ centres in India.
His work has been recognised for innovative cancer care and brings a coordinated, supportive approach to every patient journey.

Every cancer journey is personal. Read experiences shared by patients and families about the consultations, communication, follow-up and support they received at Cancer Healer Center.
4.9 Stars | 5479 Reviews
It is a blood cancer that begins in plasma cells within the bone marrow. It can damage bones but does not begin from bone-forming cells.